How have POLXF shares performed in 2024?

Polydex Pharmaceuticals' stock was trading at $1.9860 at the beginning of the year. Since then, POLXF stock has increased by 0.0% and is now trading at $1.9860. View the best growth stocks for 2024 here .

How do I buy shares of Polydex Pharmaceuticals?

Shares of POLXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:POLXF

Polydex Pharmaceuticals (POLXF) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free POLXF Stock Alerts

$1.99

+0.01 (+0.30%)

(As of 08/7/2023)

Compare

Today's Range: $1.99
▼
$1.99
50-Day Range: $1.99
▼
$1.99
52-Week Range: $0.55
▼
$2.01

Volume: 2,000 shs
Average Volume: N/A
Market Capitalization: $6.81 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Earnings

Get Polydex Pharmaceuticals alerts:

Ad Behind the Markets

The #1 Opportunity of the decade?

It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.

Click here to learn more >>>

About Polydex Pharmaceuticals Stock (OTCMKTS:POLXF)

Polydex Pharmaceuticals Ltd. is a development stage company, which engages in manufacturing of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, and the development, manufacturing, and marketing of biotechnology-based products for the human pharmaceutical market. The firm focuses on Dextran and derivative products, including Iron Dextran and Dextran Sulphate and other specialty chemicals. The company was founded by Thomas C. Usher on June 14, 1979 and is headquartered in Toronto, Canada.

POLXF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

POLXF Stock News Headlines

April 17, 2024 | americanbankingnews.com

Polydex Pharmaceuticals (OTCMKTS:POLXF) Shares Pass Below 200 Day Moving Average of $1.99

July 18, 2023 | finance.yahoo.com

Polydex Pharmaceuticals Limited Shareholders Vote to Approve BioSpectra Inc. Business Combination

April 19, 2024 | Behind the Markets (Ad)

The #1 Opportunity of the decade?

It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.

June 15, 2023 | finanznachrichten.de

Polydex Pharmaceuticals Limited: Polydex Pharmaceuticals Issues First Quarter Financial Results

April 27, 2023 | finance.yahoo.com

Polydex Pharmaceuticals Limited and BioSpectra Inc. Announce Business Combination

April 18, 2023 | barrons.com

Polydex Pharmaceuticals Ltd.

September 17, 2022 | seekingalpha.com

Polydex Pharmaceuticals GAAP EPS of -$0.09, revenue of $1.09M

September 16, 2022 | nz.finance.yahoo.com

Global Computed Tomography (CT) Scanner Market to Reach $9.38 Billion by 2028 | Demand for AI based CT Scanner is On the Rise

April 19, 2024 | Behind the Markets (Ad)

The #1 Opportunity of the decade?

It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.

August 24, 2022 | reuters.com

Polydex Pharmaceuticals Ltd

August 13, 2022 | finance.yahoo.com

Polydex Pharmaceuticals Limited (POLXF)

June 17, 2022 | seekingalpha.com

Polydex Pharmaceuticals GAAP EPS of -$0.02, revenue of $1.15M

May 4, 2022 | nz.finance.yahoo.com

Marshall Plan for Moms Mother's Day Mission: Cure Chronic Mom Guilt

May 3, 2022 | nz.finance.yahoo.com

QED Investors Hires Victoria Zuo to Help Scale Early Stage Team

May 3, 2022 | yahoo.com

Taste: Protein shakes are a great tool to meet macro goals

January 29, 2022 | nasdaq.com

Polydex Pharmaceuticals Inc (POLXF)

January 26, 2022 | finance.yahoo.com

Polydex Pharmaceuticals Announces Collaboration with Termanox Water Treatment Solutions for novel use of Native Dextran

January 5, 2022 | investing.com

Polydex Pharmaceuticals Ltd (POLXF)

December 17, 2021 | nz.finance.yahoo.com

Global Plastic Recycling Market Witnessing an Upward Growth Trajectory—Projected to Reach USD 71.5 Billion by 2027 | BlueWeave

September 16, 2021 | nz.finance.yahoo.com

TP-Link Reveals Flagship Archer AX6600 Tri-Band Wi-Fi 6 Gaming Router for just $249.99

See More Headlines

Receive POLXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Polydex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Fiscal Year End: 1/31/2025

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Industrial inorganic chemicals
Sub-Industry: N/A
Current Symbol: OTCMKTS:POLXF
CUSIP: N/A
CIK: 317158
Web: www.polydex.com
Phone: (416) 755-2231
Fax: N/A
Employees: 20
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $4.41 million
Price / Sales: 1.54
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.48 per share
Price / Book: 1.34

Miscellaneous

Outstanding Shares: 3,430,000
Free Float: 2,989,000
Market Cap: $6.81 million
Optionable: Not Optionable
Beta: N/A

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

George G. Usher
Chairman, President & Chief Executive Officer
Sharon L. Wardlaw
Chief Operating Officer, Secretary & Treasurer
David P. M. Jamestee
Chief Financial Officer
Linda C. Hughes
Head-Media & Public Relations

Key Competitors

View All Competitors

POLXF Stock Analysis - Frequently Asked Questions

How have POLXF shares performed in 2024?: Polydex Pharmaceuticals' stock was trading at $1.9860 at the beginning of the year. Since then, POLXF stock has increased by 0.0% and is now trading at $1.9860.
View the best growth stocks for 2024 here.
How do I buy shares of Polydex Pharmaceuticals?: Shares of POLXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:POLXF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Polydex Pharmaceuticals (POLXF) Stock Price, News & Analysis

About Polydex Pharmaceuticals Stock (OTCMKTS:POLXF)

POLXF Stock Price History

POLXF Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

POLXF Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info